Article
Licensed
Unlicensed
Requires Authentication
Biotechnology and the WTO: A Review of some Selective Issues
-
Der-Chin Horng
Published/Copyright:
June 19, 2006
Abstract
Biotechnology and the WTO have increasingly intersected following the growth of biotech trade. The regulatory challenge of biotechnology is a current subject of debate in the WTO. Biotechnology highlights emerging tensions between the effectiveness of the WTO law on biotech issues and the public health and the non-trade issues of biotech trade. Based on legal analysis, this paper reviews the policy issues caused by biotechnology and its implications on the organization and also considers the kind of policy options needed to achieve an appropriate balance between biotech interests and WTO discipline.
Published Online: 2006-06-19
Published in Print: 2006-03-26
© Walter de Gruyter
You are currently not able to access this content.
You are currently not able to access this content.
Articles in the same Issue
- Biotechnology and the WTO: A Review of some Selective Issues
- Conditions, Preferences and Race in Organ Donation
- Regulation of Human Embryonic Stem Cell Research in Germany
- The Paradox Facing DNA Patenting in Europe
- Informed Consent and Psychotherapy: The Travails of Consistency (Part II)
Articles in the same Issue
- Biotechnology and the WTO: A Review of some Selective Issues
- Conditions, Preferences and Race in Organ Donation
- Regulation of Human Embryonic Stem Cell Research in Germany
- The Paradox Facing DNA Patenting in Europe
- Informed Consent and Psychotherapy: The Travails of Consistency (Part II)
